Is Corbus Pharmaceuticals Holdings Inc (CRBP) Stock at the Top of the Biotechnology Industry?

Corbus Pharmaceuticals Holdings Inc (CRBP) is near the middle in its industry group according to InvestorsObserver. CRBP gets an overall rating of 43. That means it scores higher than 43 percent of stocks. Corbus Pharmaceuticals Holdings Inc gets a 49 rank in the Biotechnology industry. Biotechnology is number 77 out of 148 industries.

CRBP has an Overall Score of 43. Find out what this means to you and get the rest of the rankings on CRBP!

See Full CRBP Report

What do These Ratings Mean?

Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 43 means the stock is more attractive than 43 percent of stocks. This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in any industry with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.

What's Happening With Corbus Pharmaceuticals Holdings Inc Stock Today?

Corbus Pharmaceuticals Holdings Inc (CRBP) stock is unmoved 2.29% while the S&P 500 has gained 2.03% as of 2:53 PM on Friday, May 13. CRBP is flat $0.00 from the previous closing price of $0.21 on volume of 2,832,746 shares. Over the past year the S&P 500 has fallen -2.50% while CRBP has fallen -84.89%. CRBP lost -$0.32 per share the over the last 12 months. Click Here to get the full Stock Report for Corbus Pharmaceuticals Holdings Inc stock.